The Crucial Role of Pharmaceutical Patents in Fostering Innovation

In the realm of pharmaceuticals, patents stand as the most prevalent form of Intellectual Property Rights (IPRs). Unlike other sectors, the pharmaceutical industry leans heavily on its research and development segment, playing a pivotal role in the creation, advancement, production, and marketing of medical products. This article delves into the critical role of pharmaceutical patent in fostering pharmaceutical innovation, examining their substantial contribution to market revenue, India’s significant presence in the generic drug industry, and future trends.

The Significance of Pharmaceutical Patent

Pharmaceutical patents represent the cornerstone of intellectual property rights (IPRs) within the industry, playing a pivotal role in incentivizing pharmaceutical innovation. Unlike other sectors, where patents may serve as protective measures, in the pharmaceutical realm, they are fundamental to the very essence of innovation.

These patents provide inventors with exclusive rights to their creations, serving as shields against imitation and as catalysts for investment in research and development (R&D). Unlike industries where inventions can remain undisclosed until market release, patents in the pharmaceutical sector are inherently tied to the product itself. This unique characteristic magnifies the impact of the 20-year patent period following the filing of the application.

Moreover, patented medicines, once patented, can be easily replicated by competitors once the patent in pharma expires. Given that the industry’s capital investment primarily focuses on laboratory research and clinical trials rather than manufacturing infrastructure, the patent in pharma exclusivity becomes paramount in safeguarding these substantial investments.

Pharmaceutical Market Dynamics

The importance of pharmaceutical patent becomes even more pronounced when considering the dynamics of the global pharmaceutical market. In 2014, global pharmaceutical revenues surpassed the USD 1 trillion mark for the first time, cementing its position as a global powerhouse.

Branded and patented medicines accounted for the largest share of pharmaceutical revenues worldwide in 2018. Oncology continues to be the leading revenue-generating category. In 2018, cancer drugs alone generated nearly USD 100 billion in global revenue, while Humira, an anti-inflammatory drug, raked in approximately USD 20 billion.

top-15-pharmaceutical-products-by-sales-worldwide-in-2018-(in million U.S. dollars)
Figure 1: Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)

India: The Global Hub of Generic Drugs

India is the world’s largest contributor to generic drugs. The Indian pharmaceutical industry caters to over 50% of the global demand for various vaccines, 40% of generic demand in the US, and 25% of all medicines in the UK.

At present, Indian pharmaceutical companies supply over 80% of the global anti-retroviral drugs used to combat AIDS (Acquired Immune Deficiency Syndrome). The industry was valued at nearly USD 33 billion in 2017. India’s pharmaceutical exports, which include wholesale medicines, intermediates, pharmaceutical formulations, biologics, herbal, and surgical products, amounted to USD 17.27 billion in FY ’18, reaching USD 19.14 billion in FY ’19.

Even at the current rate of 7%-8% CAGR, the industry’s annual revenues can grow to about USD 80 to 90 billion by 2030. However, with bold aspirations of eleven to twelve percent CAGR, it could grow to annual revenues of about USD 65 billion by 2024 and about USD 120 to USD 130 billion by 2030.

indian-pharma-industry
Figure 2: Indian Pharma Industry Size by 2030

An In-depth Analysis of The Indian Pharma Industry

Indian companies received 304 abbreviated New Drug Applications (ANDA) approvals from the US Food and Drug Administration (USFDA) in 2017. The country accounts for about 30% (by quantity) and about 10% (value) of the USD 70-80 billion generic market.

India’s biotechnology sector, which includes biopharmaceuticals, bio-services, bio-agriculture, bio-industry, and bioinformatics, is expected to grow at an average annual rate of around 30% and reach nearly USD 100 billion by 2030.

The Indispensable Role of Patented Drugs

Over the years, the pharmaceutical sector has evolved, leading to the introduction of several patented drugs that have saved millions of lives. These drugs, commonly referred to as patented medicines, have also generated substantial revenue for their commercial beneficiaries.

Patented drugs enjoy a lack of price caps and competitors for about twenty years, granting the patent holder market exclusivity. In an ideal world, medicine would be accessible to all. However, the reality is that the development of new and better treatments requires significant investment. Pharmaceutical patents provide a way for pharmaceutical companies to protect this investment and continue their work in innovation.

The Future of Pharmaceutical Innovation

The future of pharmaceutical patent is bright, with new drugs being developed and patented every year. These drugs have the potential to save millions of lives and improve the quality of life for countless others. However, it’s important to remember that these advancements are only possible because of the protection provided by patents.

Looking ahead, patents will remain pivotal in driving pharmaceutical innovation forward. They serve as a safeguard for the substantial investments poured into drug development, ensuring that companies have the necessary resources to push the boundaries of medical science. As a result, we can expect to see more medical breakthroughs in the future, all thanks to the power of pharmaceutical Patent.

Final Thoughts

Pharmaceutical patents serve as the cornerstone of innovation in the pharmaceutical industry. Their role in fostering research, driving investment, and ensuring market competitiveness cannot be overstated. As we move forward, the ever-evolving landscape of healthcare, it is imperative to recognize and uphold the significance of pharmaceutical patents in shaping the future of medicine and improving global health outcomes. They are the guardians of innovation, ensuring that the future of medicine is bright and full of potential.

At Sagacious IP, we specialize in delivering customized solutions that cater to your specific requirements. Leveraging our extensive expertise, we strategically tackle your business hurdles and propose inventive solutions. Our patent filing services are designed to help organizations protect their inventions with robust patent drafts. Backed by a team of proficient patent practitioners, we ensure that your patent filing solutions are both cost-effective and of the highest quality, allowing your organization to flourish in today’s competitive environment.

– The Life Sciences and Editorial Team

Having Queries? Contact Us Now!

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

Exclusive Webinar Series
Exclusive Webinar Series. Cost: $0 (Free) Limited Seats Available. Don't miss the opportunity, Register Now